Joseph De Rutte, PhD

Partillion Bioscience, California, United States

Dr. Joe de Rutte is Co-Founder and CEO of Partillion Bioscience, a venture-backed startup commercializing the nanovial technology he pioneered during his PhD. The impact of this work was recognized by leaders in the field and he was awarded the top Innovation Award at SLAS 2020, and New Product Award in 2022. Nanovials act as millions of suspendable wells enabling researchers to perform a range of complex single-cell and molecular assays utilizing existing lab infrastructure. Current applications include antibody discovery by single B cell screening, TCR discovery, cell line development, and linked secretion and transcriptomic analysis.

Disclosure information not submitted.

Presentation(s):

• New Innovations in Omics Technologies

  Tuesday, February 6, 2024
  3:00 PM – 5:00 PM EST